Abstract
IntroductionA major determining factor on outcomes in patients with pulmonary arterial hypertension (PAH) is right ventricular (RV) function. Ranolazine, which is currently approved for chronic stable angina, has been shown...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have